Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Malaria vaccines since 2000: progress, priorities, products
Patrick E. Duffy, J. Patrick Gorres
npj Vaccines (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 212

Showing 1-25 of 212 citing articles:

Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers
Saghi Nooraei, Howra Bahrulolum, Zakieh Sadat Hoseini, et al.
Journal of Nanobiotechnology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 602
Advances and opportunities in malaria population genomics
Daniel E. Neafsey, Aimee R. Taylor, Bronwyn MacInnis
Nature Reviews Genetics (2021) Vol. 22, Iss. 8, pp. 502-517
Open Access | Times Cited: 114
Antimalarial drug discovery: progress and approaches
Jair L. Siqueira-Neto, Kathryn J. Wicht, Kelly Chibale, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 10, pp. 807-826
Open Access | Times Cited: 87
Malaria
Jeanne Rini Poespoprodjo, Nicola Davies, Daniel Ansong, et al.
The Lancet (2023) Vol. 402, Iss. 10419, pp. 2328-2345
Closed Access | Times Cited: 77
Malaria vaccines: the 60-year journey of hope and final success—lessons learned and future prospects
Amal A. El‐Moamly, Mohamed Aly El-Sweify
Tropical Medicine and Health (2023) Vol. 51, Iss. 1
Open Access | Times Cited: 46
Malaria vaccines: a new era of prevention and control
Patrick E. Duffy, J. Patrick Gorres, Sara A. Healy, et al.
Nature Reviews Microbiology (2024) Vol. 22, Iss. 12, pp. 756-772
Closed Access | Times Cited: 19
Computational Design, Expression, and Characterization of a Plasmodium falciparum Multi-epitope, Multi-stage Vaccine Candidate (PfCTMAG)
Joel M. Chick, Nadege N Abongdia, Robert Adamu Shey, et al.
Heliyon (2025) Vol. 11, Iss. 2, pp. e42014-e42014
Open Access | Times Cited: 2
Unraveling Cell Death Pathways during Malaria Infection: What Do We Know So Far?
Camille Sena-dos-Santos, Cíntia Braga-da-Silva, Diego Marques, et al.
Cells (2021) Vol. 10, Iss. 2, pp. 479-479
Open Access | Times Cited: 100
A single-cell atlas of Plasmodium falciparum transmission through the mosquito
Eliana Real, Virginia M. Howick, Farah A. Dahalan, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 78
Transmission-Blocking Vaccines: Harnessing Herd Immunity for Malaria Elimination
Patrick E. Duffy
Expert Review of Vaccines (2021) Vol. 20, Iss. 2, pp. 185-198
Open Access | Times Cited: 70
Overview of paratransgenesis as a strategy to control pathogen transmission by insect vectors
Norman A. Ratcliffe, João Pedro Furtado Pacheco, Paul Dyson, et al.
Parasites & Vectors (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 64
Malaria in 2022: Increasing challenges, cautious optimism
Prasanna Jagannathan, Abel Kakuru
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 64
Vaccine adjuvants to engage the cross-presentation pathway
Woo‐Jong Lee, M. Suresh
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 63
Malaria diagnostic methods with the elimination goal in view
Olukunle O. Oyegoke, Leah Maharaj, Oluwasegun P. Akoniyon, et al.
Parasitology Research (2022) Vol. 121, Iss. 7, pp. 1867-1885
Open Access | Times Cited: 44
Vaccination with a structure-based stabilized version of malarial antigen Pfs48/45 elicits ultra-potent transmission-blocking antibody responses
Brandon McLeod, Moustafa T. Mabrouk, Kazutoyo Miura, et al.
Immunity (2022) Vol. 55, Iss. 9, pp. 1680-1692.e8
Open Access | Times Cited: 43
mRNA vaccine against malaria tailored for liver-resident memory T cells
Mitch Ganley, Lauren E. Holz, Jordan J. Minnell, et al.
Nature Immunology (2023) Vol. 24, Iss. 9, pp. 1487-1498
Closed Access | Times Cited: 36
Dual effector population modification gene-drive strains of the African malaria mosquitoes, Anopheles gambiae and Anopheles coluzzii
Rebeca Carballar‐Lejarazú, Yuemei Dong, Thai Binh Pham, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 29
Open Access | Times Cited: 35
Vaccines and monoclonal antibodies: new tools for malaria control
Kazutoyo Miura, Yevel Flores-García, Carole A. Long, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 2
Closed Access | Times Cited: 11
Safety and Efficacy of Immunization with a Late-Liver-Stage Attenuated Malaria Parasite
Olivia A.C. Lamers, Blandine Franke‐Fayard, Jan Pieter R. Koopman, et al.
New England Journal of Medicine (2024) Vol. 391, Iss. 20, pp. 1913-1923
Closed Access | Times Cited: 10
The essential genome of Plasmodium knowlesi reveals determinants of antimalarial susceptibility
Brendan Elsworth, Sida Ye, Sheena Dass, et al.
Science (2025) Vol. 387, Iss. 6734
Closed Access | Times Cited: 1
Whole-genome sieve analysis: Identification of protective malaria antigens by leveraging allele-specific vaccine efficacy
Ryan J. Scalsky, Ankit Dwivedi, Thomas C. Stabler, et al.
Vaccine (2025) Vol. 50, pp. 126783-126783
Closed Access | Times Cited: 1
Towards Eradication of Malaria: Is the WHO’s RTS,S/AS01 Vaccination Effective Enough?
Navneet Arora, Lokhesh C Anbalagan, Ashok Kumar Pannu
Risk Management and Healthcare Policy (2021) Vol. Volume 14, pp. 1033-1039
Open Access | Times Cited: 53
Vaccines against Emerging and Neglected Infectious Diseases: An Overview
Larissa Vuitika, Wasim A. Prates-Syed, Jaqueline Dinis Queiros Silva, et al.
Vaccines (2022) Vol. 10, Iss. 9, pp. 1385-1385
Open Access | Times Cited: 32
Current approaches to malaria vaccines
Patrick E. Duffy
Current Opinion in Microbiology (2022) Vol. 70, pp. 102227-102227
Open Access | Times Cited: 31
Potent transmission-blocking monoclonal antibodies from naturally exposed individuals target a conserved epitope on Plasmodium falciparum Pfs230
Danton Ivanochko, Amanda Fabra-García, Karina Teelen, et al.
Immunity (2023) Vol. 56, Iss. 2, pp. 420-432.e7
Open Access | Times Cited: 20
Page 1 - Next Page

Scroll to top